Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Neoplasms of the CNS

  Free Subscription


Articles published in J Neuropathol Exp Neurol

Retrieve available abstracts of 91 articles:
HTML format



Single Articles


    December 2021
  1. KRONISH A, DeNardo B, Kanach C, Lulla RR, et al
    Activating BRAF G469A Missense Mutation in a Pediatric Patient With High-Grade Glioma.
    J Neuropathol Exp Neurol. 2021;80:1141-1142.
    PubMed    


  2. KIMURA T, Ikedo T, Ohta-Ogo K, Hamano E, et al
    A Pathologically Verified Case of Peripheral Intracranial Aneurysmal Formation With Massively Infiltrating Meningioma Cells.
    J Neuropathol Exp Neurol. 2021 Dec 29. pii: 6487232. doi: 10.1093.
    PubMed    


  3. SASAKI S, Takeda M, Hirose T, Fujii T, et al
    Correlation of MTAP Immunohistochemistry With CDKN2A Status Assessed by Fluorescence In Situ Hybridization and Clinicopathological Features in CNS WHO Grade 2 and 3 Meningiomas: A Single Center Cohort Study.
    J Neuropathol Exp Neurol. 2021 Dec 13. pii: 6460154. doi: 10.1093.
    PubMed     Abstract available


  4. ROSAGER AM, Dahlrot RH, Sorensen MD, Bangso JA, et al
    The Epigenetic Regulator Jumonji Domain-Containing Protein 6 (JMJD6) Is Highly Expressed but Not Prognostic in IDH-Wildtype Glioblastoma Patients.
    J Neuropathol Exp Neurol. 2021 Dec 7. pii: 6454863. doi: 10.1093.
    PubMed     Abstract available


  5. LARKIN CJ, Jennings LJ, Heimberger AB, Horbinski C, et al
    Next-Generation Sequencing of a Glioblastoma with True Epithelial Differentiation.
    J Neuropathol Exp Neurol. 2021 Dec 3. pii: 6448594. doi: 10.1093.
    PubMed    


    November 2021
  6. UHLMANN EJ, Rabinovsky R, Varma H, El Fatimy R, et al
    Tumor-Derived Cell Culture Model for the Investigation of Meningioma Biology.
    J Neuropathol Exp Neurol. 2021 Nov 28. pii: 6445140. doi: 10.1093.
    PubMed     Abstract available


  7. LIND KT, Chatwin HV, DeSisto J, Coleman P, et al
    Novel RAF Fusions in Pediatric Low-Grade Gliomas Demonstrate MAPK Pathway Activation.
    J Neuropathol Exp Neurol. 2021 Nov 28. pii: 6445141. doi: 10.1093.
    PubMed     Abstract available


  8. CHKHEIDZE R, Raisanen J, Gagan J, Richardson TE, et al
    Alterations in the RB Pathway With Inactivation of RB1 Characterize Glioblastomas With a Primitive Neuronal Component.
    J Neuropathol Exp Neurol. 2021 Nov 28. pii: 6445139. doi: 10.1093.
    PubMed     Abstract available


    October 2021
  9. OON ML, Low SYY, Kuick CH, Goh JY, et al
    An Unusual Ganglioglioma with Pseudopapillary Features and PRKAR2B-BRAF Fusion.
    J Neuropathol Exp Neurol. 2021;80:1000-1003.
    PubMed    


  10. LIN CC, Mansukhani MM, Bruce JN, Canoll P, et al
    Rosette-Forming Glioneuronal Tumor in the Pineal Region: A Series of 6 Cases and Literature Review.
    J Neuropathol Exp Neurol. 2021;80:933-943.
    PubMed     Abstract available


  11. AHN JS, Ervin J, Cummings TJ, Lopez GY, et al
    Papillary Glioneuronal Tumor With a Novel GPR37L1-PRKCA Fusion.
    J Neuropathol Exp Neurol. 2021;80:1004-1006.
    PubMed    


    September 2021
  12. AHRENDSEN JT, Sinai C, Meredith DM, Malinowski SW, et al
    Molecular Alterations in Pediatric Low-Grade Gliomas That Led to Death.
    J Neuropathol Exp Neurol. 2021 Sep 27. pii: 6377085. doi: 10.1093.
    PubMed     Abstract available


  13. KARPATHIOU G, Ferrand E, Camy F, Babiuc SM, et al
    Expression of STAT6 and Phosphorylated STAT6 in Primary Central Nervous System Lymphomas.
    J Neuropathol Exp Neurol. 2021;80:830-834.
    PubMed     Abstract available


  14. LIN CC, Lefferts JA, Chan AM, Zanazzi G, et al
    Rare Activating BRAF Alteration Involving the beta3-alphaC Kinase Domain in Ganglioglioma.
    J Neuropathol Exp Neurol. 2021;80:887-889.
    PubMed    


  15. SMITH HL, Collins J, Park D, Darlington W, et al
    Pediatric Gliomas Presenting with Gliomatosis-Like Spread, Lack of Contrast Enhancement, EGFR Mutation, and TERT Promoter Variants.
    J Neuropathol Exp Neurol. 2021 Sep 15. pii: 6370674. doi: 10.1093.
    PubMed    


  16. CHEN J, Lee H, Schmitt P, Choy CJ, et al
    Bioengineered Models to Study Microenvironmental Regulation of Glioblastoma Metabolism.
    J Neuropathol Exp Neurol. 2021 Sep 15. pii: 6370675. doi: 10.1093.
    PubMed     Abstract available


  17. SUGITA Y, Hashimoto G, Fukuda K, Takahashi K, et al
    Primary Nondural Central Nervous System Marginal ZoneB-Cell Lymphoma of the Mucosa-Associated Lymphoid Tissue Type Mimicking CNS Inflammatory Diseases.
    J Neuropathol Exp Neurol. 2021;80:789-799.
    PubMed     Abstract available


  18. AHANGARI N, Munoz DG, Coulombe J, Gray DA, et al
    Nuclear IMPDH Filaments in Human Gliomas.
    J Neuropathol Exp Neurol. 2021 Sep 8. pii: 6366485. doi: 10.1093.
    PubMed     Abstract available


    August 2021
  19. MOVAHED-EZAZI M, Skalina KA, Parashar K, Manjila S, et al
    A Rare Presentation of Low-Grade Prostate Adenocarcinoma as Delayed Pineal Region Metastasis: A Case Report and Review of Multicenter Clinical Experience in Prostate Carcinoma Brain Metastases.
    J Neuropathol Exp Neurol. 2021 Aug 13. pii: 6350804. doi: 10.1093.
    PubMed    


  20. LEBRUN L, Bizet M, Melendez B, Alexiou B, et al
    Analyses of DNA Methylation Profiling in the Diagnosis of Intramedullary Astrocytomas.
    J Neuropathol Exp Neurol. 2021;80:663-673.
    PubMed     Abstract available


  21. COVELLI C, Parente P, Icolaro N, Dimitri LMC, et al
    Primary Epithelioid Hemangioma of the Central Nervous System: A Case Report and Review of the Literature.
    J Neuropathol Exp Neurol. 2021;80:717-719.
    PubMed    


    July 2021
  22. FOIANI G, Guelfi G, Mandara MT
    MicroRNA Dysregulation in Canine Meningioma: RT-qPCR Analysis of Formalin-Fixed Paraffin-Embedded Samples.
    J Neuropathol Exp Neurol. 2021 Jul 17. pii: 6323287. doi: 10.1093.
    PubMed     Abstract available


  23. PROSNIAK M, Kenyon LC, Hooper DC
    Glioblastoma Contains Topologically Distinct Proliferative and Metabolically Defined Subpopulations of Nestin- and Glut1-Expressing Cells.
    J Neuropathol Exp Neurol. 2021 Jul 16. pii: 6322918. doi: 10.1093.
    PubMed     Abstract available


    June 2021
  24. LUCAS CG, Devine P, Solomon DA, Giannini C, et al
    Sarcomatous Meningioma: Diagnostic Pitfalls and the Utility of Molecular Testing.
    J Neuropathol Exp Neurol. 2021 Jun 12. pii: 6297520. doi: 10.1093.
    PubMed     Abstract available


    May 2021
  25. KNUDSEN AM, Rudkjobing SJ, Sorensen MD, Dahlrot RH, et al
    Expression and Prognostic Value of the Immune Checkpoints Galectin-9 and PD-L1 in Glioblastomas.
    J Neuropathol Exp Neurol. 2021 May 15. pii: 6276054. doi: 10.1093.
    PubMed     Abstract available


  26. HIRAKI T, Fukuoka K, Mori M, Arakawa Y, et al
    Application of Genome-Wide DNA Methylation Analysis to Differentiate a Case of Radiation-Induced Glioblastoma From Late-Relapsed Medulloblastoma.
    J Neuropathol Exp Neurol. 2021 May 15. pii: 6276056. doi: 10.1093.
    PubMed     Abstract available


    April 2021
  27. GOSCHZIK T, Zur Muehlen A, Doerner E, Waha A, et al
    Medulloblastoma in Adults: Cytogenetic Phenotypes Identify Prognostic Subgroups.
    J Neuropathol Exp Neurol. 2021;80:419-430.
    PubMed     Abstract available


  28. STEPHEN NIX J, Ida CM
    What Every Neuropathologist Needs to Know: Practical Aspects and Pitfalls in Molecular Diagnosis of Brain Tumors.
    J Neuropathol Exp Neurol. 2021 Apr 9. pii: 6219399. doi: 10.1093.
    PubMed     Abstract available


    March 2021
  29. DAHL NA, Donson AM, Sanford B, Wang D, et al
    NTRK Fusions Can Co-Occur With H3K27M Mutations and May Define Druggable Subclones Within Diffuse Midline Gliomas.
    J Neuropathol Exp Neurol. 2021 Mar 22. pii: 6179633. doi: 10.1093.
    PubMed     Abstract available


  30. RICHARDSON TE, Sathe AA, Xing C, Mirchia K, et al
    Molecular Signatures of Chromosomal Instability Correlate With Copy Number Variation Patterns and Patient Outcome in IDH-Mutant and IDH-Wildtype Astrocytomas.
    J Neuropathol Exp Neurol. 2021;80:354-365.
    PubMed     Abstract available


  31. ULLOA-NAVAS MJ, Rubio L, Teruel-Sanchis A, Pena-Pena J, et al
    Heterogeneous Pattern of Differentiation With BCAS1/NABC1 Expression in a Case of Oligodendroglioma.
    J Neuropathol Exp Neurol. 2021;80:379-383.
    PubMed    


  32. PHAM K, Maxwell MJ, Sweeney H, Alt J, et al
    Novel Glutamine Antagonist JHU395 Suppresses MYC-Driven Medulloblastoma Growth and Induces Apoptosis.
    J Neuropathol Exp Neurol. 2021 Mar 13. pii: 6169464. doi: 10.1093.
    PubMed     Abstract available


    February 2021
  33. SMITH MJ, Pathmanaban ON, Coope DJ, King AT, et al
    Comment on: SMARCB1 Gene Mutation Predisposes to Earlier Development of Glioblastoma: A Case Report of Familial GBM.
    J Neuropathol Exp Neurol. 2021;80:289-290.
    PubMed    


  34. FONKEM E, Peng S, Berens M, Mukherjee S, et al
    Authors' Reply: SMARCB1 Gene Mutation Predisposes to Earlier Development of Glioblastoma: A Case Report of Familial GBM.
    J Neuropathol Exp Neurol. 2021;80:290-291.
    PubMed    


  35. MIYAKE Y, Fujii K, Nakamaura T, Ikegaya N, et al
    IDH-Mutant Astrocytoma With Chromosome 19q13 Deletion Manifesting as an Oligodendroglioma-Like Morphology.
    J Neuropathol Exp Neurol. 2021;80:247-253.
    PubMed     Abstract available


  36. DAOUD EV, Patel A, Gagan J, Raisanen JM, et al
    Spinal Cord Pilocytic Astrocytoma With FGFR1-TACC1 Fusion and Anaplastic Transformation.
    J Neuropathol Exp Neurol. 2021;80:283-285.
    PubMed    


  37. PRYZBYLSKI AL, Kollmeyer TM, Praska CE, Raghunathan A, et al
    Non-canonical IDH Mutation Frequency in IDH1-R132H-Negative Glioblastoma Patients Older Than 54 Years.
    J Neuropathol Exp Neurol. 2021 Feb 7. pii: 6130116. doi: 10.1093.
    PubMed    


  38. HEALY E
    Corrigendum to: SMARCB1 Gene Mutation Predisposes to Earlier Development of Glioblastoma: A Case Report of Familial GBM.
    J Neuropathol Exp Neurol. 2021 Feb 4. pii: 6127560. doi: 10.1093.
    PubMed    


    January 2021
  39. MOVAHED-EZAZI M, Schwartz PJ, Zimmerman DL, Song X, et al
    Subependymal Giant Cell Astrocytoma in a 79-Year-Old Woman without Clinical Features of Tuberous Sclerosis: A Case Report.
    J Neuropathol Exp Neurol. 2021;80:199-201.
    PubMed    


  40. YEUNG J, Yaghoobi V, Aung TN, Vesely MD, et al
    Spatially Resolved and Quantitative Analysis of the Immunological Landscape in Human Meningiomas.
    J Neuropathol Exp Neurol. 2021 Jan 4. pii: 6061497. doi: 10.1093.
    PubMed     Abstract available


  41. HOLSTEN T, Lubieniecki F, Spohn M, Mynarek M, et al
    Detailed Clinical and Histopathological Description of 8 Cases of Molecularly Defined CNS Neuroblastomas.
    J Neuropathol Exp Neurol. 2021;80:52-59.
    PubMed     Abstract available


  42. BARRESI V, Simbolo M, Gessi M, Rossi S, et al
    Clinical-Pathological, Immunohistochemical, and Genetic Characterization of a Series of Posterior Pituitary Tumors.
    J Neuropathol Exp Neurol. 2021;80:45-51.
    PubMed     Abstract available


  43. ARCHILLA I, Guerrero J, Reyes Figueroa LA, Capurro S, et al
    Intra-Axial Frontal Cyst with Ependymoma-Like Proliferation: Neuroectodermal or Neurenteric?
    J Neuropathol Exp Neurol. 2021;80:93-95.
    PubMed    


    December 2020
  44. WANG YH, Huang TL, Chen X, Yu SX, et al
    Glioma-Derived TSP2 Promotes Excitatory Synapse Formation and Results in Hyperexcitability in the Peritumoral Cortex of Glioma.
    J Neuropathol Exp Neurol. 2020 Dec 31. pii: 6056628. doi: 10.1093.
    PubMed     Abstract available


  45. MITANI Y, Fukuoka K, Mori M, Arakawa Y, et al
    Clinical Aggressiveness of TP53-Wild Type Sonic Hedgehog Medulloblastoma With MYCN Amplification, Chromosome 17p Loss, and Chromothripsis.
    J Neuropathol Exp Neurol. 2020 Dec 25. pii: 6047589. doi: 10.1093.
    PubMed    


  46. GOODMAN AL, Velazquez Vega JE, Rey Martinez LC, Brat DJ, et al
    Epithelioid Pituicytoma: Expanding the Morphologic Spectrum of a Rare Neoplasm.
    J Neuropathol Exp Neurol. 2020;79:1376-1378.
    PubMed    


    November 2020
  47. NATSUMEDA M, Miyahara H, Yoshimura J, Nakata S, et al
    GLI3 Is Associated With Neuronal Differentiation in SHH-Activated and WNT-Activated Medulloblastoma.
    J Neuropathol Exp Neurol. 2020 Nov 29. pii: 6010620. doi: 10.1093.
    PubMed     Abstract available


  48. ALSAFWANI N, Alrjoub M, Djuric U, Gao A, et al
    Tumor-Infiltrating Lymphocytes Are Enriched in Nonhypoxic Glioblastoma Niches.
    J Neuropathol Exp Neurol. 2020 Nov 19. pii: 5992386. doi: 10.1093.
    PubMed    


  49. YAO K, Duan Z, Du Z, Fan X, et al
    PRKCA D463H Mutation in Chordoid Glioma of the Third Ventricle: A Cohort of 16 Cases, Including Two Cases Harboring BRAFV600E Mutation.
    J Neuropathol Exp Neurol. 2020;79:1183-1192.
    PubMed     Abstract available


  50. NAVALKELE P, Guzman M, Kirby A, Pinz H, et al
    Familial Pediatric Clear Cell Meningioma With Germline SMARCE1 Mutation in the United States.
    J Neuropathol Exp Neurol. 2020;79:1250-1252.
    PubMed    


  51. GILBERT AR, Yan L, McDougall CM
    Broadening the Age of Incidence of Intracranial Angiomatoid Fibrous Histiocytoma With EWSR1-CREM Fusion: A Case Report.
    J Neuropathol Exp Neurol. 2020;79:1244-1246.
    PubMed    


  52. SAN-MIGUEL T, Navarro L, Sanchez-Sendra B, Megias J, et al
    Identification of a Novel BRCA1 Alteration in Recurrent Melanocytoma Resulting in Increased Proliferation.
    J Neuropathol Exp Neurol. 2020;79:1233-1238.
    PubMed     Abstract available


  53. ZHENG H, Baranova K, Song J, Yan L, et al
    Overexpression of Long Noncoding RNA HOTAIR Is a Unique Epigenetic Characteristic of Myxopapillary Ependymoma.
    J Neuropathol Exp Neurol. 2020;79:1193-1202.
    PubMed     Abstract available


    October 2020
  54. SALLE H, Durand K, Gantois C, Labrousse F, et al
    Myxoid Meningioma: First Report of a Rare Metaplastic Meningioma Variant in the Pineal Region.
    J Neuropathol Exp Neurol. 2020 Oct 17. pii: 5928920. doi: 10.1093.
    PubMed    


  55. RICHARDSON TE, Kumar A, Xing C, Hatanpaa KJ, et al
    Overcoming the Odds: Toward a Molecular Profile of Long-Term Survival in Glioblastoma.
    J Neuropathol Exp Neurol. 2020;79:1031-1037.
    PubMed     Abstract available


  56. MORRIS M, Driscoll M, Henson JW, Cobbs C, et al
    Low-Grade Gemistocytic Morphology in H3 G34R-Mutant Gliomas and Concurrent K27M Mutation: Clinicopathologic Findings.
    J Neuropathol Exp Neurol. 2020;79:1038-1043.
    PubMed     Abstract available


  57. GITTO L, Serinelli S, Galbraith K, Williams M, et al
    Anaplastic Transformation in Myxopapillary Ependymoma: A Report of 2 Cases and Review of the Literature.
    J Neuropathol Exp Neurol. 2020;79:1044-1053.
    PubMed     Abstract available


    September 2020
  58. DAL COL P, Poncet D, Rivoirard R, Vassal F, et al
    Acquired ATRX Loss and ALT Phenotype Through Tumor Recurrences in a Case of Pleomorphic Xanthoastrocytoma Suggest Their Possible Roles in Tumor Progression.
    J Neuropathol Exp Neurol. 2020;79:1011-1014.
    PubMed     Abstract available


    August 2020
  59. PETTERSON SA, Sorensen MD, Kristensen BW
    Expression Profiling of Primary and Recurrent Glioblastomas Reveals a Reduced Level of Pentraxin 3 in Recurrent Glioblastomas.
    J Neuropathol Exp Neurol. 2020 Aug 13. pii: 5892401. doi: 10.1093.
    PubMed     Abstract available


  60. QI S, Liu Y, Wang C, Fan J, et al
    Membrane Structures Between Craniopharyngioma and the Third Ventricle Floor Based on the QST Classification and Its Significance: A Pathological Study.
    J Neuropathol Exp Neurol. 2020 Aug 13. pii: 5892406. doi: 10.1093.
    PubMed     Abstract available


  61. TANG K, Gardner S, Snuderl M
    The Role of Liquid Biopsies in Pediatric Brain Tumors.
    J Neuropathol Exp Neurol. 2020 Aug 7. pii: 5882050. doi: 10.1093.
    PubMed     Abstract available


  62. MIKKELSEN VE, Dai HY, Stensjoen AL, Berntsen EM, et al
    MGMT Promoter Methylation Status Is Not Related to Histological or Radiological Features in IDH Wild-type Glioblastomas.
    J Neuropathol Exp Neurol. 2020;79:855-862.
    PubMed     Abstract available


  63. ZANAZZI G, Pendrick D, Lin CC, Higgins D, et al
    Pineal Region High-Grade Glioneuronal Tumor With a Novel ZBTB10-NTRK3 Fusion.
    J Neuropathol Exp Neurol. 2020;79:929-931.
    PubMed    


  64. TANG K, Kurland D, Vasudevaraja V, Serrano J, et al
    Exploring DNA Methylation for Prognosis and Analyzing the Tumor Microenvironment in Pleomorphic Xanthoastrocytoma.
    J Neuropathol Exp Neurol. 2020;79:880-890.
    PubMed     Abstract available


    July 2020
  65. FURUTA T, Sugita Y, Komaki S, Ohshima K, et al
    The Multipotential of Leucine-Rich alpha-2 Glycoprotein 1 as a Clinicopathological Biomarker of Glioblastoma.
    J Neuropathol Exp Neurol. 2020 Jul 10. pii: 5869580. doi: 10.1093.
    PubMed     Abstract available


  66. GALBRAITH K, Kumar A, Abdullah KG, Walker JM, et al
    Molecular Correlates of Long Survival in IDH-Wildtype Glioblastoma Cohorts.
    J Neuropathol Exp Neurol. 2020 Jul 10. pii: 5869581. doi: 10.1093.
    PubMed     Abstract available


  67. HUIZER K, Zhu C, Chirifi I, Krist B, et al
    Periostin Is Expressed by Pericytes and Is Crucial for Angiogenesis in Glioma.
    J Neuropathol Exp Neurol. 2020 Jul 10. pii: 5869578. doi: 10.1093.
    PubMed     Abstract available


  68. MORISAKO T, Shishido-Hara Y, Inaba T, Takeuchi H, et al
    Primary CNS CD45-Depleted T-Cell Lymphoma: The First Pathologically Confirmed Case.
    J Neuropathol Exp Neurol. 2020;79:817-820.
    PubMed    


  69. SHAHAB S, Rubens J, Kaur H, Sweeney H, et al
    MEK Inhibition Suppresses Growth of Atypical Teratoid/Rhabdoid Tumors.
    J Neuropathol Exp Neurol. 2020;79:746-753.
    PubMed     Abstract available


    June 2020
  70. KAM KL, Appin CL, Mao Q, Ikegami S, et al
    Is Next-Generation Sequencing Alone Sufficient to Reliably Diagnose Gliomas?
    J Neuropathol Exp Neurol. 2020 Jun 1. pii: 5850092. doi: 10.1093.
    PubMed     Abstract available


    May 2020
  71. GAUCHOTTE G, Peyre M, Pouget C, Cazals-Hatem D, et al
    Prognostic Value of Histopathological Features and Loss of H3K27me3 Immunolabeling in Anaplastic Meningioma: A Multicenter Retrospective Study.
    J Neuropathol Exp Neurol. 2020 May 24. pii: 5843545. doi: 10.1093.
    PubMed     Abstract available


  72. ZHU LY, Wu XY, Liu XD, Zheng DF, et al
    Aggressive Medulloblastoma-Derived Exosomal miRNAs Promote In Vitro Invasion and Migration of Tumor Cells Via Ras/MAPK Pathway.
    J Neuropathol Exp Neurol. 2020 May 17. pii: 5838430. doi: 10.1093.
    PubMed     Abstract available


  73. MUKHERJEE S, Stroberg E, Wang F, Morales L, et al
    SMARCB1 Gene Mutation Predisposes to Earlier Development of Glioblastoma: A Case Report of Familial GBM.
    J Neuropathol Exp Neurol. 2020;79:562-565.
    PubMed     Abstract available


  74. AHRENDSEN JT, Hsu N, Wolf Z, Bryke C, et al
    Multiple Whole Chromosomal Gains Define Angiomatous Meningiomas and Are Absent From the Tumor Vasculature.
    J Neuropathol Exp Neurol. 2020 May 1. pii: 5827861. doi: 10.1093.
    PubMed     Abstract available


    March 2020
  75. FIORAVANZO A, Caffo M, Di Bonaventura R, Gardiman MP, et al
    A Risk Score Based on 5 Clinico-Pathological Variables Predicts Recurrence of Atypical Meningiomas.
    J Neuropathol Exp Neurol. 2020 Mar 31. pii: 5814172. doi: 10.1093.
    PubMed     Abstract available


  76. NAKATA S, Price A, Eberhart C, Morris M, et al
    Increased Tau Expression Correlates With IDH Mutation in Infiltrating Gliomas and Impairs Cell Migration.
    J Neuropathol Exp Neurol. 2020 Mar 17. pii: 5809104. doi: 10.1093.
    PubMed     Abstract available


  77. BALLESTER LY, Meis JM, Lazar AJ, Prabhu SS, et al
    Intracranial Myxoid Mesenchymal Tumor With EWSR1-ATF1 Fusion.
    J Neuropathol Exp Neurol. 2020;79:347-351.
    PubMed     Abstract available


  78. SALLE H, Pocard M, Lehmann-Che J, Bourthoumieu S, et al
    Development of a Novel Orthotopic Primary Human Chordoma Xenograft Model: A Relevant Support for Future Research on Chordoma.
    J Neuropathol Exp Neurol. 2020;79:314-324.
    PubMed     Abstract available


    February 2020
  79. BODOR C, Alpar D, Marosvari D, Galik B, et al
    Molecular Subtypes and Genomic Profile of Primary Central Nervous System Lymphoma.
    J Neuropathol Exp Neurol. 2020;79:176-183.
    PubMed     Abstract available


    January 2020
  80. D'ARCY CE, Nobre LF, Arnaldo A, Ramaswamy V, et al
    Immunohistochemical and nanoString-Based Subgrouping of Clinical Medulloblastoma Samples.
    J Neuropathol Exp Neurol. 2020 Jan 30. pii: 5735424. doi: 10.1093.
    PubMed     Abstract available


  81. HEWER E, Phour J, Gutt-Will M, Schucht P, et al
    TERT Promoter Mutation Analysis to Distinguish Glioma From Gliosis.
    J Neuropathol Exp Neurol. 2020 Jan 29. pii: 5740035. doi: 10.1093.
    PubMed     Abstract available


  82. HO CY, Bornhorst M, Almira-Suarez MI, Donev K, et al
    Clinicopathologic Features of Diencephalic Neuronal and Glioneuronal Tumors.
    J Neuropathol Exp Neurol. 2020;79:67-73.
    PubMed     Abstract available


  83. KLEINSCHMIDT-DEMASTERS BK
    Pituitary Adenomas in Transgender Individuals?
    J Neuropathol Exp Neurol. 2020;79:62-66.
    PubMed     Abstract available


    December 2019
  84. MARTIN AM, Bell WR, Yuan M, Harris L, et al
    PD-L1 Expression in Pediatric Low-Grade Gliomas Is Independent of BRAF V600E Mutational Status.
    J Neuropathol Exp Neurol. 2019 Dec 9. pii: 5670883. doi: 10.1093.
    PubMed     Abstract available


    November 2019
  85. PI CASTRO D, Jose-Lopez R, Fernandez Flores F, Rabanal Prados RM, et al
    Expression of FOXP3 in Canine Gliomas: Immunohistochemical Study of Tumor-Infiltrating Regulatory Lymphocytes.
    J Neuropathol Exp Neurol. 2019 Nov 11. pii: 5679984. doi: 10.1093.
    PubMed     Abstract available


    September 2019
  86. RICHARDSON TE, Tang K, Vasudevaraja V, Serrano J, et al
    GOPC-ROS1 Fusion Due to Microdeletion at 6q22 Is an Oncogenic Driver in a Subset of Pediatric Gliomas and Glioneuronal Tumors.
    J Neuropathol Exp Neurol. 2019 Sep 16. pii: 5593615. doi: 10.1093.
    PubMed     Abstract available


  87. CHKHEIDZE R, Cimino PJ, Hatanpaa KJ, White CL, et al
    Distinct Expression Patterns of Carbonic Anhydrase IX in Clear Cell, Microcystic, and Angiomatous Meningiomas.
    J Neuropathol Exp Neurol. 2019 Sep 12. pii: 5582700. doi: 10.1093.
    PubMed     Abstract available


    February 2019
  88. XU C, Mao L, Xiong J, Wen J, et al
    TAZ Expression on Endothelial Cells Is Closely Related to Blood Vascular Density and VEGFR2 Expression in Astrocytomas.
    J Neuropathol Exp Neurol. 2019;78:172-180.
    PubMed     Abstract available


  89. AHN JS, Harrison W, Hughes E, McLendon RE, et al
    Intraventricular Pilocytic Astrocytoma With KIAA1549/BRAF Fusion Arising in a 44-Year Old.
    J Neuropathol Exp Neurol. 2019;78:187-190.
    PubMed     Abstract available


    January 2019
  90. DAOUD EV, Wachsmann M, Richardson TE, Mella D, et al
    Spinal Pleomorphic Xanthoastrocytoma With a QKI-RAF1 Fusion.
    J Neuropathol Exp Neurol. 2019;78:10-14.
    PubMed     Abstract available


  91. LIPP ES, Healy P, Austin A, Clark A, et al
    MGMT: Immunohistochemical Detection in High-Grade Astrocytomas.
    J Neuropathol Exp Neurol. 2019;78:57-64.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: